Document
PGR2025-00032, No. 1063 Exhibit - Petition for Post Grant Review of US Patent No 11,007,201 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1063 Exhibit - Petition for Post Grant Review of US Patent No 11,007,201 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1002-2 Exhibit - US Prosecution History of the ’166 Patent Part 2 of 6 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1002-2 Exhibit - US Prosecution History of the ’166 Patent Part 2 of 6 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1053 Exhibit - Sarafoglou Phase 3 Trial of Crinecerfont Sarafoglou et al 2024 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1053 Exhibit - Sarafoglou Phase 3 Trial of Crinecerfont Sarafoglou et al 2024 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1036 Exhibit - US Patent No 10,849,908 to Alexis Howerton, et al (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1036 Exhibit - US Patent No 10,849,908 to Alexis Howerton, et al (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1027 Exhibit - Neurocrine March 20, 2021, Press Release (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1027 Exhibit - Neurocrine March 20, 2021, Press Release (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1021 Exhibit - Merke Cutler “New Ideas for Medical Treatment Merke Cutler 2001 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1021 Exhibit - Merke Cutler “New Ideas for Medical Treatment Merke Cutler 2001 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1004 Exhibit - Declaration of David E Bugay, PhD (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1004 Exhibit - Declaration of David E Bugay, PhD (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1002-5 Exhibit - US Prosecution History of the ’166 Patent Part 5 of 6 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1002-5 Exhibit - US Prosecution History of the ’166 Patent Part 5 of 6 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1066 Exhibit - Spierling Zorrilla, Don’t stress about CRF Assessing (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1066 Exhibit - Spierling Zorrilla, Don’t stress about CRF Assessing (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1001 Exhibit - US Patent No 12,115,166 to Alexis Howerton, et al “the ’166 patent” (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1001 Exhibit - US Patent No 12,115,166 to Alexis Howerton, et al “the ’166 patent” (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1037 Exhibit - US Patent No 11,007,201 B2 to Alexis Howerton, et al (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1037 Exhibit - US Patent No 11,007,201 B2 to Alexis Howerton, et al (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1013 Exhibit - Speiser et al, “Congenital Adrenal Hyperplasia Speiser 2010 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1013 Exhibit - Speiser et al, “Congenital Adrenal Hyperplasia Speiser 2010 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1031 Exhibit - Kehne Cain “Therapeutic Utility of Non Peptidic CRF1 Kehne Cain 2010 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1031 Exhibit - Kehne Cain “Therapeutic Utility of Non Peptidic CRF1 Kehne Cain 2010 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1020 Exhibit - Gully et al, J Pharmacol Exp Ther, Gully 2002 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1020 Exhibit - Gully et al, J Pharmacol Exp Ther, Gully 2002 (P.T.A.B. Feb. 10, 2025)
+ More Snippets
Document
PGR2025-00032, No. 1039 Exhibit - Sarafoglou “Interpretation of Steroid Biomarkers in 21 Sarafoglou 2023 (P.T.A.B. Feb. 10, 2025)
Cite Document
PGR2025-00032, No. 1039 Exhibit - Sarafoglou “Interpretation of Steroid Biomarkers in 21 Sarafoglou 2023 (P.T.A.B. Feb. 10, 2025)
+ More Snippets